All data used for this research were extracted from the REIN registry, coordinated and supported by the French Biomedecine Agency. The access to national data is regulated by a scientific committee of French Biomedecine Agency which analyzes each request, and so cannot be made publicly available due to legal restrictions. Data are available upon request. If readers need information about the data from the REIN registry, they can contact Dr. Cecile Couchoud who coordinates the REIN at the national level (email adress: <cecile.couchoud@biomedecine.fr>).

Introduction {#sec005}
============

Renal transplantation is the optimal treatment for end-stage renal disease (ESRD). It is associated with increased quality of life \[[@pone.0153431.ref001],[@pone.0153431.ref002]\], lower mortality and morbidity \[[@pone.0153431.ref003]--[@pone.0153431.ref005]\].

In developed countries, many studies found that age, gender and comorbidities \[[@pone.0153431.ref006],[@pone.0153431.ref007]\] are associated with access to the renal transplant waiting list \[[@pone.0153431.ref008],[@pone.0153431.ref009]\] and mortality \[[@pone.0153431.ref010]\]. Moreover, social inequalities in the access to the transplant waiting lists and to renal transplantation have been highlighted in the United States of America (USA) and United Kingdom (UK). These disparities may be related to several individual and neighborhood-related factors. Specifically, some works suggested a role for various non-medical individual factors, such as health insurance status \[[@pone.0153431.ref011]\], employment status \[[@pone.0153431.ref012]\] and education level \[[@pone.0153431.ref013]\]. Previous epidemiological studies also showed a social gradient of ESRD \[[@pone.0153431.ref014],[@pone.0153431.ref015]\] and access to the transplant waiting list \[[@pone.0153431.ref016]--[@pone.0153431.ref019]\]. Indeed, people living in deprived neighborhoods are more likely to start renal replacement therapy and less likely to be wait-listed. However, the results of studies on access to renal transplantation after being waitlisted and on patients' survival are contradictory \[[@pone.0153431.ref008],[@pone.0153431.ref016]\]. The meta-analysis carried out by Morton et al. found consistent evidences that disadvantaged individuals with chronic kidney disease (CKD) have poorer access to quality treatment, including renal transplantation \[[@pone.0153431.ref020]\]. Studies in the USA suggest that the socio-economic status is a potential determinant of access to health care \[[@pone.0153431.ref021]\] that can influence the likelihood of placement on the renal transplant waiting list and of renal transplantation. In France, the access to diagnosis could be affected by neighborhood deprivation \[[@pone.0153431.ref022]\]; however, the national health insurance system covers the entire population and, therefore, ESRD treatment should not be limited by the patients' socio-economic status. Moreover, medical and hospital costs for patients with CKD are completely covered (100%) and the reimbursement is regulated according to uniform rates, regardless of whether the patient is treated in public or private-sector nephrology facilities.

To our knowledge, few studies have investigated the impact of both patients' medical features and non-medical contextual factors on the access to the renal transplant waiting list, renal transplantation and patients' survival. These works assessed the influence of individual or neighborhood-related factors (deprivation, or degree of urbanization) on renal transplantation or on survival. However, most of them focused on racial disparities and investigated mainly the effect of poverty on these disparities \[[@pone.0153431.ref018],[@pone.0153431.ref023]\].

In France, no study has assessed the social inequalities of access to renal transplantation. After a study on the socio-spatial inequalities of ESRD incidence in Bretagne \[[@pone.0153431.ref022]\], here we investigated the social inequalities in (i) the access to the renal transplant waiting list, (ii) access to renal transplantation after being wait-listed and (iii) patients' survival, by taking into account both individual and neighborhood characteristics (neighborhood deprivation and degree of urbanization) of the smallest geographic unit (census block), in Bretagne, a French region.

Material and Methods {#sec006}
====================

Study setting {#sec007}
-------------

This study was carried out in Bretagne, one of the administrative regions in France. Bretagne is a mixed urban and rural region, located in the western part of France, with a population of 3,094,000 inhabitants in 2006.

Data source and participants' selection {#sec008}
---------------------------------------

This study included a cohort of adult patients who lived in Bretagne and started dialysis (incident cases) between January 1, 2004 and December 31, 2009. This cohort was extracted from the French national "Réseau Epidémiologie et Information en Néphrologie" (REIN) registry \[[@pone.0153431.ref024],[@pone.0153431.ref025]\]. The patients' residential address was retrieved and matched to the corresponding census block. Preemptively transplanted patients were not included.

Covariates {#sec009}
----------

Five categories of variables were studied:

1.  Demographic data: age group (18--39, 40--59, 60--69, ≥70 years), sex and occupational status.

2.  Clinical features at first dialysis: body mass index (BMI), hemoglobin and serum albumin, primary renal disease (categorized in six groups: glomerulonephritis, pyelonephritis, diabetic nephropathy, hypertensive and vascular nephropathy, polycystic kidney disease and other causes/unknown) and comorbidities. The Comorbidities included in this analysis were: cardiovascular disease (coronary artery disease, peripheral vascular disease, congestive heart failure, arrhythmia, aortic aneurysm and cerebrovascular disease), diabetes, chronic respiratory disease, hepatic disease, active malignancy and physical disabilities (physical impairment of ambulation, para- or hemiplegia, blindness, member amputation).

3.  Data concerning the medical follow-up in nephrology centers: ownership of nephrology facility where the first dialysis was performed (public university centers, public non-university centers and private centers), date of first dialysis, emergency *vs* planned first dialysis session, type of first dialysis (hemodialysis (HD) or peritoneal dialysis (PD)), date of placement on the waiting list, date of renal transplantation and date of death.

4.  Blood type and Panel Reactive Antibody (PRA) for patients registered on the waiting list and donor type (deceased or living) for patients who underwent renal transplantation.

5.  Two neighborhood characteristics at the census-block level: (i) degree of urbanization (rural/ urban typology) and (ii) socio-economic deprivation index. The residential census block of each patient was classified as urban or rural \[[@pone.0153431.ref022]\] using an approach inspired from the study by Van Eupene al., 2012 \[[@pone.0153431.ref026]\]. The urban/rural typology was defined by combining two criteria of rural/urban classification: the population density, using the OECD typology (Organization for Economic Co-operation and Development) \[[@pone.0153431.ref027]\] and land cover \[[@pone.0153431.ref028]\] (for more details, see Kihal et al., 2015 \[[@pone.0153431.ref022]\]). For the socio-economic deprivation index, socio-economic and demographic data were obtained from the 2006 census at the census-block level. To characterize the neighborhood deprivation level, a deprivation index was used that included variables related to education, income, occupation, unemployment and immigration to cover and capture the different dimensions of deprivation. Successive principal-component analyses were performed to calculate the deprivation index, based on Lalloue et al. \[[@pone.0153431.ref029]\], in each considered geographic area (rural/urban). The measure of neighborhood deprivation was categorized in three groups (low, moderate or high deprivation) according to the tertiles of the index distribution \[[@pone.0153431.ref022]\].

Outcomes measures {#sec010}
-----------------

The outcomes of interest included:

1.  Access to the renal transplant waiting list: patients placed on the waiting list before starting dialysis were considered to be wait-listed at first dialysis. Time to wait-listing was calculated from the date of first dialysis. Not wait-listed patients were censored at the date of death or at the end of the follow-up period (December 31, 2011).

2.  Access to renal transplantation after placement on the list: patients who received renal transplant from a living donor were excluded from the analyses. Time to renal transplantation was calculated from the date of placement on the waiting list. Non-transplanted patients were censored at the date of death or at the end of the follow-up period.

3.  Survival: time to death was calculated from the date of the first dialysis. Living patients were censored at the end of the follow-up period. Renal transplantation was considered as a time- dependent covariate.

Statistical analyses {#sec011}
--------------------

Cox proportional hazards models were used to identify the factors associated with the likelihood of (i) being placed on the waiting list, (ii) being transplanted after placement on the waiting list and (iii) survival. Patients with missing data were excluded from the analyses.

First, univariate Cox regression analyses were performed to assess associations between the outcomes and the patients' characteristics (including neighborhood data). Then, multivariate Cox models were constructed using variables with a p-value lower than 0.2 in univariate analyses and variables that were selected *a priori*, based on literature findings (gender and neighborhood deprivation). Results were reported as hazard ratios (HR) with 95% confidence interval (CI) and p-values. Statistical significance was identified by a p-value lower than 0.05. All analyses were performed using the STATA software (version11.2).

Ethics statement {#sec012}
----------------

This retrospective study was approved by the French Biomedecine Agency and included patients' data that were anonymized and de-identified directly in the REIN database before extraction for the analysis.

Patients and the associated data were extracted from the French REIN registry that was approved by CNIL (Commission Nationale de l'Information et des Libertés) in 2010. REIN is registered with the CNIL under the following number: 903188 Version 3.

Results {#sec013}
=======

Participants' characteristics {#sec014}
-----------------------------

Data concerning 2006 incident patients who lived in Bretagne and started dialysis between January 2004 and December 2009 were extracted from the REIN registry. By the end of 2011, 27% of them were registered on the transplant waiting list and 24% had received a kidney transplant mostly from deceased donors (five living donors). Moreover, 931 patients (46%) died during the follow-up period.

Among the 2006 patients, 56.1% were older than 70 years (mean age: 67.3 years), 60.6% males, 79.1% without occupation, 26% had diabetes, 54.5% had cardiovascular diseases, 47.2% lived in a rural area, 50% in census-blocks with high socio-economic deprivation and 18.7% in areas with low deprivation ([Table 1](#pone.0153431.t001){ref-type="table"}).

10.1371/journal.pone.0153431.t001

###### Patients' characteristics at first dialysis and their association with access to the waiting list (univariate and multivariate Cox analyses).

![](pone.0153431.t001){#pone.0153431.t001g}

  Patients' characteristics                              Number (%)     Univariate analysis    Multivariate analysis                          
  ------------------------------------------------------ -------------- ---------------------- ----------------------- ---------------------- ---------
  **Age**                                                                                                                                      
  18--39                                                 122 (6.1)      54.52 \[36.7--81.1\]   \<0.001                 29.81 \[18.1--49.1\]   \<0.001
  40--59                                                 425 (21.2)     38.10 \[24.4--54.9\]   \<0.001                 23.50 \[15.2--36.4\]   \<0.001
  60--69                                                 334 (16.6)     12.15 \[8.2--18.0\]    \<0.001                 11.00 \[7.01--17.2\]   \<0.001
  ≥70                                                    1125 (56.1)    1                                              1                       
  **Sex **                                                                                                                                     
  Men                                                    1216 (60.6)    1.06 \[0.9--1.2\]      0.49                    1.01 \[0.8--1.2\]      0.9
  Women                                                  790 (39.4)     1                                              1                       
  **Occupational status**                                                                                                                      
  Yes                                                    264 (14.3)     8.38\[7.0--10.2\]      \<0.001                 1.61 \[1.3--2.0\]      \<0.001
  No                                                     1587 (85.7)    1                                              1                       
  **BMI [†](#t001fn001){ref-type="table-fn"} (kg/m2)**                                                                                         
  \<20                                                   262 (14)       0.98 \[0.7--1.3\]      0.87                    \-                      
  \[20--25\[                                             783 (41.8)     1                                              \-                      
  \[25--30 \[                                            537 (28.7)     0.85 \[0.7--1.1\]      0.14                    \-                      
  \[30--35 \[                                            212 (11.3)     1.02 \[0.8--1.3\]      0.85                    \-                      
  ≥35                                                    79 (4.2)       0.46 \[0.3--0.8\]      0.008                   \-                      
  **Serum albumin (g/dl)**                                                                                                                     
  \<30                                                   347 (20.6)     0.47 \[0.3--0.6\]      \<0.001                 \-                      
  ≥30                                                    1334 (79.4)    1                                                                      
  **Hemoglobin (g/dl)**                                                                                                                        
  \<10                                                   600 (32.7)     1.04 \[0.8--1.3\]      0.64                    \-                      
  \[10--12\[                                             879 (47.9)     1                                              \-                      
  ≥12                                                    356 (19.4)     1.31 \[1.1--1.6\]      0.02                    \-                      
  **Type of dialysis**                                                                                                                         
  HD                                                     1756 (87.5)    0.85 \[0.7--1.1\]      0.20                    \-                      
  DP                                                     250 (12.5)     1                                              \-                      
  **Emergency first dialysis session**                                                                                                         
  Yes                                                    558 (71.4)     0.67 \[0.5--0.8\]      \<0.001                 0.59 \[0.5--0.8\]      \<0.001
  No                                                     1393(28.6)     1                                              1                       
  **Ownership of dialysis facility**                                                                                                           
  Private                                                791(39.4)      2.16 \[1.8--2.6\]      \<0.001                 1.4 1\[1.1--1.7\]      0.001
  Public, non-university                                 943(47.0)      1                                              1                       
  Public, university                                     272 (13.6)     0.52 \[0.4--0.8\]      0.001                   0.64 \[0.4--1.0\]      0.06
  **Primary renal disease**                                                                                                                    
  APKD [^**‡**^](#t001fn002){ref-type="table-fn"}        76 (3.8)       1                                              1                       
  Hypertensive & vascular                                481 (24.0)     0.14 \[0.1--0.2\]      \<0.001                 0.72 \[0.5--1.0\]      0.07
  Other & unknown                                        786 (39.2)     0.26 \[0.2--0.3\]      \<0.001                 0.62 \[0.5--0.8\]      \<0.001
  Diabetes                                               187 (9.3)      0.25 \[0.2--0.4\]      \<0.001                 0.67 \[0.4--0.98\]     0.04
  Glomerulonephritis                                     267 (13.3)     0.64 \[0.5--0.8\]      0.001                   0.85 \[0.6--1.1\]      0.28
  Pyelonephritis                                         108 (5.4)      0.59 \[0.4--0.8\]      0.003                   0.77 \[0.5--1.1\]      0.19
  **Cardiovascular disease**                                                                                                                   
  Yes                                                    1058 (54.5)    0.20 \[0.2--0.3\]      0.001                   0.52 \[0.4--0.7\]      \<0.001
  No                                                     883 (45.5)     1                                              1                       
  **Chronic respiratory disease**                                                                                                              
  Yes                                                    239 (87.5)     0.38 \[0.3--0.6\]      \<0.001                 \-                      
  No                                                     1668(12.5)     1                                              \-                      
  **Active malignancy**                                                                                                                        
  Yes                                                    217 (11.4)     0.18 \[0.1--0.3\]      \<0.001                 0.28 \[0.2--0.5\]      \<0.001
  No                                                     1689 (88.6     1                                              1                       
  **Diabetes**                                                                                                                                 
  Yes                                                    505 (26.0)     0.49 \[0.4--0.6\]      \<0.001                 \-                      
  No                                                     1437 (74.0)    1                                              \-                      
  **Physical disabilities**                                                                                                                    
  Yes                                                    335 (17.6)     0.18 \[0.1--0.3\]      \<0.001                 0.48 \[0.3--0.8\]      0.002
  No                                                     1566 (82.4)    1                                              1                       
  **Hepatic disease**                                                                                                                          
  Yes                                                    1 832 (96.3)   0.21 \[0.1--0.5\]      0.001                   0.23 \[0.1--0.6\]      \<0.001
  No                                                     70 (3.7)       1                                              1                       
  **Neighborhood deprivation**                                                                                                                 
  Low                                                    75(18.7)       1.40 \[1.1--1.7\]      0.002                   1.04 \[0.8--1.3\]      \>0.5
  Moderate                                               628(31.3)      1.06 \[0.9--1.3\]      0.53                    1.14 \[0.9--1.4\]      0.7
  High                                                   1003(50.0)     1                                              1                       
  **Degree of urbanization**                                                                                                                   
  Rural                                                  946 (47.2)     1                                              \-                      
  Urban                                                  1060 (52.8)    0.86 \[0.7--1.0\]      0.09                    \-                      

^†^ Body Mass Index

‡ polycystic kidney disease

HD: hemodialysis; PD: peritoneal dialysis

Among the patients placed on the waiting list (n = 546), 5.9% were older than 70 years, 61.5% were males and 56.1% without occupation, 16.3% had diabetes, 21.6% had cardiovascular diseases, 50.7% lived in a rural area, 46.1% were from highly disadvantaged and 23.6% from less disadvantaged census-blocks.

Access to the renal transplant waiting list ([Table 1](#pone.0153431.t001){ref-type="table"}) {#sec015}
---------------------------------------------------------------------------------------------

### (a) Univariate analysis {#sec016}

Occupation, young age, high hemoglobin level (≥12 g/dl) and private ownership of the nephrology facility were significantly associated with higher access to the transplant waiting list. The presence of co-morbidities, physical disabilities, low serum albumin level (\<30 g/dl), high BMI value (≥35kg/m²), emergency first dialysis (*vs* planned one) and all primary renal diseases (compared with polycystic kidney disease) were significantly associated with a lower probability of being wait-listed. Patients living in less disadvantaged census-blocks had higher access to the waiting list than those living in highly disadvantaged areas. Similarly, access to the waiting list was higher for patients living in urban areas than for those living in rural census-blocks.

### (b) Multivariate analysis {#sec017}

Young patients (18--39 years) were more likely to be placed on the waiting list (aHR = 29.81 95%CI: \[18.1--49.1\]). Patients with a cardiovascular disease, hepatic disease, active malignancy or physical disability were less likely to be placed on the list than patients without comorbidity (adjusted HR, aHR = 0.52 95%CI: \[0.4--0.7\]; aHR = 0.23 95%CI: \[0.1--0.6\]; aHR = 0.28 95%CI: \[0.2--0.5\]; aHR = 0.48 95%CI: \[0.3--0.8\], respectively). Similarly, emergency first dialysis session was still associated with a lower probability of being wait-listed (aHR = 0.59 95%CI: \[0.5--0.8\]). Patients followed in private facilities were 41% more likely to be registered on the waiting list than patients followed in public non university centers. Conversely, neighborhood deprivation was not significantly associated with access to the waiting list in multivariate analysis.

Access to deceased donor renal transplantation after being wait-listed ([Table 2](#pone.0153431.t002){ref-type="table"}) {#sec018}
------------------------------------------------------------------------------------------------------------------------

### (a) Univariate analysis {#sec019}

Patients aged ≥70 years or with the A or AB blood groups (compared with the O group) had higher access to renal transplantation. Conversely, the presence of diabetes and active malignancy at first dialysis, diabetic nephropathy (compared with polycystic kidney disease) and hyperimmunisation (PRA ≥85%) were associated with lower access to renal transplantation. Neighborhood deprivation and rural/urban typology were not significantly associated with access to renal transplantation.

10.1371/journal.pone.0153431.t002

###### Association between patients' characteristics and access to renal transplantation after placement on the waiting list (univariate and multivariate Cox analyses).

![](pone.0153431.t002){#pone.0153431.t002g}

  Patients' characteristics                             Number (%)   Univariate analysis   Multivariate analysis                        
  ----------------------------------------------------- ------------ --------------------- ----------------------- -------------------- ---------
  **Age**                                                                                                                                
  18--39                                                104 (19.0)   1                                             1                     
  40--59                                                302 (55.3)   1.00 \[0.8--1.3\]     0.93                    0.86 \[0.7--1.1\]    0.16
  60--69                                                108 (19.8)   1.04\[0.8--1.4\]      0.74                    0.89 \[0.7--1.2\]    0.20
  ≥70                                                   32 (5.9)     1.61\[1.1--2.4\]      0.02                    1.72 \[1.1--2.6\]    0.01
  **Gender**                                                                                                                             
  Men                                                   336 (61.5)   1.01 \[0.8--1.2\]     0.90                    0.95 \[0.8--1.2\]    0.71
  Women                                                 210 (38.5)   1                                             1                     
  **Occupation status**                                                                                                                  
  No                                                    281 (56.1)   1                                                                   
  Yes                                                   220 (43.9)   1.12 \[0.9--1.3\]     0.23                                          
  **Blood group**                                                                                                                        
  O                                                     258 (47.3)   1                                             1                     
  A                                                     207 (37.9)   1.95 \[1.6--2.4\]     \<0.001                 2.17 \[1.8--2.8\]    \<0.001
  B                                                     22 (4.0)     0.69 \[0.5-.0.9\]     0.02                    0.70 \[0.5--0.9\]    0.045
  AB                                                    59 (10.8)    2.08 \[1.3--3.3\]     0.002                   1.89 \[1.1--3.13\]   0.047
  **Panel Reactive Antibody (PRA)**                                                                                                      
  %\<85                                                 525 (96.1)   1                                             1                     
  ≥85                                                   21 (3.9)     0.63 \[0.4--1.0\]     0.05                    0.57 \[0.4--0.93\]   0.027
  **BMI[\*](#t002fn001){ref-type="table-fn"}(kg/m2)**                                                                                    
  \<20                                                  73 (13.9)    0.83 \[0.6--1.1\]     0.2                     \-                    
  \[20--25\[                                            232 (44.1)   1                                             \-                    
  \[25--30 \[                                           141 (26.8)   0.94 \[0.7--1.2\]     0.61                    \-                    
  \[30--35 \[                                           67(12.7)     0.78 \[0.6--1.1\]     0.11                    \-                    
  ≥35                                                   13 (2.5)     0.93 \[0.5--1.7\]     0.81                    \-                    
  **Serum albumin (g/dl)**                                                                                                               
  \<30                                                  52 (11.0)    0.76 \[0.5--1.1\]     0.09                    \-                    
  ≥30                                                   420 (89)     1                                             \-                    
  **Hemoglobin (g/dl)**                                                                                                                  
  \<10                                                  163 (31.8)   1.01 \[0.8--1.3\]     0.85                                          
  \[10--12\[                                            232 (45.2)   1                                                                   
  ≥12                                                   118 (23)     0.93 \[0.7--1.2\]     0.58                                          
  **Type of dialysis **                                                                                                                  
  HD                                                    473 (86.6)   0.88 \[0.7--1.2\]     0.37                                          
  DP                                                    73 (13.4)    1                                                                   
  **Ownership of dialysis facility**                                                                                                     
  Private                                               318 (58.2)   1.17 \[1.0--1.4\]     0.09                    \-                    
  Public, non-university                                198 (36.3)   1                                             \-                    
  Public, university                                    30 (5.5)     1.33 \[0.9--2.1\]     0.19                    \-                    
  **Emergency first dialysis session**                                                                                                   
  Yes                                                   115 (21.1)   0.95 \[0.8--1.2\]     0.67                                          
  No                                                    423 (77.5)   1                                                                   
  **Primary renal disease**                                                                                                              
  APKD[\*\*](#t002fn002){ref-type="table-fn"}           110 (20.2)   1                                             \-                    
  Hypertensive & vascular                               61 (11.2)    1.03 \[0.7--1.4\]     0.83                    \-                    
  Other &unknown                                        164 (30.0)   0.71 \[0.6--0.99\]    0.04                    \-                    
  Diabetes                                              41 (7.5)     0.65 \[0.4--0.98\]    0.04                    \-                    
  Glomerulonephritis                                    124 (22.7)   0.91 \[0.7--1.2\]     0.51                    \-                    
  Pyelonephritis                                        46 (8.4)     0.98 \[0.7--1.4\]     0.92                    \-                    
  **Cardiovascular disease **                                                                                                            
  Yes                                                   114 (21.6)   0.84 \[0.7--1.1\]     0.15                    0.74 \[0.6--0.9\]    0.017
  No                                                    414 (78.4)   1                                             1                     
  **Chronic respiratory disease**                                                                                                        
  Yes                                                   28 (5.3)     0.67 \[0.43--1.0\]    0.07                    \-                    
  No                                                    495(94.6)    1                                             \-                    
  **Active malignancy **                                                                                                                 
  Yes                                                   13 (2.5)     0.46 \[0.2--0.97\]    0.04                    \-                    
  No                                                    504 (97.5)   1                                             \-                    
  **Diabetes**                                                                                                                           
  Yes                                                   86 (16.3)    0.70 \[0.5--0.9\]     0.01                    \-                    
  No                                                    443 (83.7)   1                                                                   
  **Physical disabilities**                                                                                                              
  Yes                                                   19 (3.6)     0.58 \[0.3--1.0\]     0.07                     -                    
  No                                                    506 (96.4)   1                                              -                    
  **Hepatic disease**                                                                                                                    
  Yes                                                   5 (1.0)      0.72 \[0.2--2.3\]     0.57                                          
  No                                                    512 (99.0)   1                                                                   
  **Neighborhood deprivation**                                                                                                           
  Low                                                   129 (23.6)   0.88 \[0.7--1.1\]     0.29                    0.86 \[0.7--1.1\]    0.26
  Moderate                                              165 (30.2)   0.99 \[0.8--1.2\]     0.95                    1.03 \[0.8--1.3\]    0.90
  High                                                  252 (46.2)   1                                             1                     
  **Degree of urbanization**                                                                                                             
  Rural                                                 277(50.7)    0.97 \[0.8--1.2\]     0.76                                          
  Urban                                                 269 (49.3)   1                                                                   

\* Body Mass Index

\*\* Polycystic kidney disease

HD: hemodialysis; PD: peritoneal dialysis

### (b) Multivariate analysis {#sec020}

Patients aged ≥70 years (compared with the 18--39 year/old group) were 72% more likely to receive a transplant. Conversely, all clinical data at first dialysis, type of primary renal disease and type of first dialysis were no longer associated with the probability of undergoing transplantation. Among comorbidities, only cardiovascular diseases remained significantly associated with a lower probability of transplantation (aHR = 0.74 95%CI: \[0.6--0.9\]).

Patients with A or AB blood group were still more likely (two times) to receive a kidney transplant than O group patients. Conversely, B blood group and high degree of immunization were associated with a lower probability of receiving a renal transplant (aHR = 0.70 95%CI: \[0.5--0.9\]; aHR = 0.57 95%CI: \[0.4--0.93\], respectively).

After adjustment for the patients' features, the likelihood of renal transplantation was not significantly different in the different socio-economic areas, although it was slightly lower for patients living in advantaged neighborhoods than for patients living in deprived areas (aHR = 0.86 95%CI: \[0.7--1.1\]).

Patients' survival ([Table 3](#pone.0153431.t003){ref-type="table"}) {#sec021}
--------------------------------------------------------------------

### (a) Univariate analysis {#sec022}

Low BMI (\<20 kg/m²), low serum albumin level (\<30 g/dl), presence of comorbidities, physical disabilities, emergency first dialysis and all primary renal diseases (compared with polycystic kidney disease) were significantly associated with higher mortality risk. Compared with patients followed in public non university centers, the mortality risk was lower for patients followed in private centers and higher for those followed in public university facilities. Transplantation during the follow-up period was associated with lower mortality risk. Neighborhood deprivation was significantly associated with higher mortality; conversely, the degree of urbanization was not associated with the mortality risk.

10.1371/journal.pone.0153431.t003

###### Association between patients' characteristics at first dialysis and mortality (univariate and multivariate Cox analyses).
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  Patients' characteristics                             Univariate analysis   Multivariate analysis                         
  ----------------------------------------------------- --------------------- ----------------------- --------------------- ---------
  **Age**                                                                                                                    
  18--39                                                0.05 \[0.0--0.1\]     \<0.001                 0.18 \[0.1--0.4\]     \<0.001
  40--59                                                0.18 \[0.1--0.2\]     \<0.001                 0.40 \[0.3--0.5\]     \<0.001
  60--69                                                0.42 \[0.3--0.5\]     \<0.001                 0.47 \[0.4--0.6\]     \<0.001
  \> = 70                                               1                                             1                      
  **Sex**                                                                                                                    
  Men                                                   1.11 \[0.98--1.3\]    0.09                    1.1 \[0.9--1.34\]     0.120
  women                                                 1                                             1                      
  **Occupation status**                                                                                                      
  Yes                                                   0.09 \[0.06--0.15\]   \<0.001                 \-                    \-
  No                                                    1                                                                    
  **BMI[\*](#t003fn001){ref-type="table-fn"}(kg/m2)**                                                                        
  \<20                                                  1.27 \[1.04--1.6\]    0.01                    1.43 \[1.-1.8\]       0.003
  \[20--25\[                                            1                                             1                      
  \[25--30 \[                                           1.00 \[0.8--1.2\]     0.92                    0.90 \[0.7--1.1\]     0.30
  \[30--35 \[                                           0.99 \[0.8--1.2\]     0.96                    0.87 \[0.7--1.1\]     0.33
  ≥35                                                   0.82 \[0.6--1.0\]     0.33                    0.63 \[0.4--1.04\]    0.06
  **Serum albumin (g/dl)**                                                                                                   
  \<30                                                  1.80 \[1.5--2.1\]     \<0.001                 1.3 \[1.1--1.6\]      0.003
  ≥30                                                   1                                             1                      
  **Hemoglobin (g/dl)**                                                                                                      
  \<10                                                  1.05 \[0.9--1.2\]     0.48                    \-                     
  \[10--12\[                                            1                                             \-                     
  ≥12                                                   0.83 \[0.7--1.0\]     0.06                    \-                     
  **Type of dialysis **                                                                                                      
  HD                                                    0.82 \[0.7--0.99\]    0.05                    0.77 \[0.6--0.96\]    0.026
  DP                                                    1                                             1                      
  **Emergency first dialysis session**                                                                                       
  Yes                                                   1.31 \[1.1--1.5\]     \<0.001                 \-                    \-
  No                                                    1                                             \-                     
  **Renal transplantation**                                                                                                  
  Yes                                                   0.08 \[0.05--0.1\]    \<0.001                 0.25 \[0.2--0.4\]     \<0.001
  No                                                    1                                             1                      
  **Primary renal disease**                                                                                                  
  APKD[\*\*](#t003fn002){ref-type="table-fn"}           1                                             1                      
  Hypertensive & vascular                               5.38 \[3.6--8.0\]     \<0.001                 2.50 \[1.5--4.17\]    \<0.001
  Other & unknown                                       4.44 \[3.0--6.6\]     \<0.001                 2.70 \[1.6--4.5\]     \<0.001
  Diabetes                                              4.32 \[2.8--6.6\]     \<0.001                 2.64 \[1.5--4.6\]     \<0.001
  Glomerulonephritis                                    2.16 \[1.4--3.3\]     \<0.001                 1.72 \[0.99--2.99\]   0.053
  Pyelonephritis                                        2.45 \[1.5--4.0\]     \<0.001                 2.32 \[1.3--4.28\]    0.007
  **Ownership of dialysis facility**                                                                                         
  Private                                               0.64 \[0.6--0.7\]     \<0.001                 \-                    \-
  Public, non-university                                1                                             \-                    \-
  Public university                                     1.49 \[1.2--1.8\]     \<0.001                 \-                    \-
  **Cardiovascular disease**                                                                                                 
  Yes                                                   3.40 \[2.9--3.9\]     \<0.001                 1.83 \[1.5--2.2\]     \<0.001
  No                                                    1                                             1                      
  **Chronic respiratory disease**                                                                                            
  Yes                                                   1.76 \[1.5--2.1\]     \<0.001                 1.40 \[1.1--1.7\]     0.002
  No                                                    1                                             1                      
  **Active malignancy**                                                                                                      
  Yes                                                   2.33\[1.9--2.8\]      \<0.001                 1.51 \[1.2--1.89\]    \<0.001
  No                                                    1                                             1                      
  **Diabetes**                                                                                                               
  Yes                                                   1.44\[1.2--1.7\]      \<0.001                 \-                     
  No                                                    1                                             \-                     
  **Physical disabilities**                                                                                                  
  Yes                                                   2.94 \[2.5--3.4\]     \<0.001                 1.8 \[1.5--2.2\]      \<0.001
  No                                                    1                                             1                      
  **Hepatic disease**                                                                                                        
  Yes                                                   1.64 \[1.2--2.2\]     0.001                   \-                     
  No                                                    1                                             \-                     
  **Neighborhood deprivation**                                                                                               
  Low                                                   0.82 \[0.7--0.98\]    0.03                    0.98 \[0.8--1.24\]    0.9
  Moderate                                              1.02\[0.9--1.2\]      0.73                    1.13 \[0.95--1.35\]   0.13
  High                                                  1                                             1                      
  **Degree of urbanization**                                                                                                 
  Urban                                                 1.06\[0.9--1.2\]      0.35                                           
  Rural                                                 1                                                                    

\* Body Mass Index

\*\* Polycystic kidney disease

HD: hemodialysis; PD: peritoneal dialysis

### (b) Multivariate analysis {#sec023}

Patients aged between 18 and 39 (compared with the ≥70 year/old group) had a lower risk of death (aHR: 0.18\[0.1--0.4\]). Patients with a cardiovascular disease, respiratory disease, active malignancy, or physical disabilities had a higher mortality risk (aHR = 1.83 95%CI: \[1.5--2.2\]; aHR = 1.40 95%CI: \[1.1--1.7\]; aHR = 1.51 95%CI: \[1.2--1.89\]; aHR = 1.81 95%CI: \[1.5--2.2\], respectively). Low BMI values (\<20 g/dl) were associated with higher probability of death (aHR = 1.43 95%CI: \[1.0--1.8\]). Transplantation during the follow-up period was associated with lower probability of death (aHR = 0.25 95%CI: \[0.2--0.4\]).

After adjustment for the patients' clinical features, the likelihood of mortality was no longer associated with neighborhood deprivation, although it was slightly lower among patients living in advantaged than among those living in deprived areas (aHR = 0.98 95%CI: \[0.8--1.2\]).

Discussion {#sec024}
==========

This first contextual study in France on the role of socio-economic factors in the access to renal transplantation or patients' survival shows that, after taking into account the patients' clinical features, neighborhood deprivation and degree of urbanization are not associated with access to the renal transplant waiting list, transplantation after placement on the list or survival.

To our knowledge, no other study on the access to renal transplantation has taken into account both patients' clinical features and neighborhood characteristics (socio-economic level and urbanization degree) at a fine spatial level in mixed urban and rural areas. Indeed, most studies focused either on racial disparities or on poverty \[[@pone.0153431.ref018],[@pone.0153431.ref023]\], without considering the urbanization degree \[[@pone.0153431.ref008],[@pone.0153431.ref016],[@pone.0153431.ref030],[@pone.0153431.ref031]\]. Moreover, in contrast with previous reports from the USA, the UK and Scotland \[[@pone.0153431.ref008],[@pone.0153431.ref019],[@pone.0153431.ref032]--[@pone.0153431.ref037]\], our study took into account all major comorbidities.

Although our univariate analysis showed that patients living in highly deprived neighborhoods had less chance to be placed on the waiting list, this association did not remain after taking into account other patients' characteristics. In the USA \[[@pone.0153431.ref016]--[@pone.0153431.ref018],[@pone.0153431.ref038]\] and in the UK \[[@pone.0153431.ref008],[@pone.0153431.ref019]\], all studies found that patients living in a highly deprived neighborhood were less likely to be placed on the waiting list. Moreover, a higher social adaptability index (SAI) was associated with increased likelihood of being wait-listed \[[@pone.0153431.ref016]\].

Our findings show that the likelihood of renal transplantation after placement on the list and risk of death were slightly, but not significantly, lower among patients living in advantaged neighborhoods. Contradictory results were reported by previous epidemiological studies. Indeed, while some authors found that patients had an equal chance of transplantation, regardless of their socioeconomic status \[[@pone.0153431.ref008],[@pone.0153431.ref039]\], others showed that patients living in advantaged neighborhoods had a greater likelihood of receiving a transplant \[[@pone.0153431.ref016],[@pone.0153431.ref031]\]). Conversely, neighborhood poverty \[[@pone.0153431.ref040]\] or lower median income \[[@pone.0153431.ref017]\] was associated with a reduced probability of transplantation \[[@pone.0153431.ref017]\]). Another study found that neighborhoods with low level of deprivation were associated with reduced mortality risk \[[@pone.0153431.ref030]\] and that mortality was higher for patients living in the poorest areas \[[@pone.0153431.ref040]\] only among Asians and Pacific Islanders. On the other hand, another work reported that the risk of death was lower among patients living in deprived neighborhoods \[[@pone.0153431.ref031]\].

Overall, studies carried out in the USA and UK show that neighborhood deprivation plays an important role; conversely, our study suggests that neighborhood deprivation is not a determinant factor for receiving renal transplantation. These conflicting results may be due to health care system differences between the USA, the UK and France (universal health care system). Indeed, this finding is plausible because in France, the national health insurance system covers the entire population. Moreover, people living in deprived neighborhoods have often more comorbidities (diabetes, cardiovascular diseases...) and malnutrition. These factors can limit the access to the waiting list. Therefore, if the patient's medical condition is not taken into account during the analysis, the neighborhood deprivation effect may in reality reflect the comorbidity influence \[[@pone.0153431.ref014]\]. In addition, neighborhood deprivation may be associated with nephrologists' clinical practice patterns. Our study was performed in Bretagne where there are two transplantation centers. This might have reduced the bias related to clinical practice variations and increased the possibility to analyze factors directly related to patients.

These conflicting results could also be partially explained by the use of different deprivation measures (composite indexes \[[@pone.0153431.ref031]\], SAI \[[@pone.0153431.ref016],[@pone.0153431.ref030]\], Carstairs score \[[@pone.0153431.ref008]\] or Townsend \[[@pone.0153431.ref019]\], poverty level \[[@pone.0153431.ref018],[@pone.0153431.ref038],[@pone.0153431.ref040]\] and income level \[[@pone.0153431.ref017]\]) to study how the access to the waiting list and to kidney transplant is affected by socio-economic variables. In our work, we used a neighborhood deprivation index that included variables related to education, income, occupation, unemployment and immigration to cover different dimensions of deprivation in rural and urban settings. This deprivation index has been validated and previously used to demonstrate socio-economic gradients in the incidence of ESRD in Bretagne \[[@pone.0153431.ref022]\] and of infant mortality in Lyon \[[@pone.0153431.ref041],[@pone.0153431.ref042]\].

The second main finding of our study is that the degree of urbanization, like the neighborhood socio-economic features, does not influence the access to the transplant waiting list, to transplantation after being wait-listed and patients' survival. A few recent studies revealed conflicting results. A study found that the urbanization degree of the patient's residence was not associated with the time on the waiting listing \[[@pone.0153431.ref038]\]. Conversely, other works have shown that the likelihood of placement on the list \[[@pone.0153431.ref043]\] and of transplantation \[[@pone.0153431.ref043]\] was slightly, but significantly higher for people living in rural areas than for those residing in urban areas. Studies in the USA found that white non-Hispanic and Native American patients living in rural areas were more likely to undergo transplantation than those living in urban areas \[[@pone.0153431.ref044]\]. Conversely, in Rotterdam, low urbanization grade significantly and negatively influenced the chance of living donor transplantation \[[@pone.0153431.ref039]\].

Our study has some limitations. Race/ethnic differences were not recorded in the French ESRD registry because the French legislation does not allow collecting this kind of information. Data about the individual socio-economic status and about individual preferences were not available and were thus not included in our analysis. However, we chose a fine geographical scale, designed to be as homogeneous as possible in terms of socio-economic characteristics. The census block homogeneity allowed minimizing the ecological bias and the results can be considered as close as possible to what can be observed at the individual level.

Conclusion {#sec025}
==========

In this study, we assessed social inequalities at a fine scale in a mixed rural and urban French region. Our results show that, after taking into account all major patients' clinical characteristics, patients living in deprived neighborhoods and those living in advantaged ones had the same chance to be placed on the waiting list, to be transplanted and the same mortality risk. In France where everybody is covered by the national health insurance, the association observed, in univariate analysis, between higher neighborhood deprivation and lower access to renal transplantation is more related to the patients' clinical features than to socio-economic factors, or nephrologists' clinical practices.
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